Fortis Healthcare Ltd

Mid Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Fortis Healthcare stock has confirmed a breakout above a key pattern, indicating a new uptrend. Momentum indicators support this bullish outlook, with targets set at ₹1,000-₹1,020.

Fortis Healthcare Stock Signals Strong Bullish Trend - 27 Feb, 2026

Analyst insights suggest Fortis Healthcare's share price could reach ₹990, supported by a bullish chart pattern. A new breast care clinic launch enhances the company's service offerings.

Fortis Healthcare Target Price Set at ₹990 - 26 Feb, 2026

Fortis Healthcare's largest shareholder, IHH Healthcare, plans to accelerate expansion in India. Axis Securities has assigned a Buy rating, forecasting significant growth and operational improvements.

Fortis Healthcare Receives Positive Rating and Expansion Plans - 20 Feb, 2026

Fortis Healthcare received multiple buy recommendations from analysts following strong Q3 results, with target prices ranging from ₹1,050 to ₹1,150, indicating positive market sentiment.

Fortis Healthcare Analysts Upgrade Ratings and Targets - 17 Feb, 2026

Fortis Healthcare reported a decline in net profit despite revenue growth. The company plans to expand bed capacity and expects revenue growth in the coming years. IHH Healthcare is increasing its investment to support Fortis's growth.

Fortis Healthcare Reports Mixed Q3 Results and Growth Plans - 16 Feb, 2026

Fortis Healthcare's Q3 results show a 21.8% drop in profit to ₹193.7 crore, despite a 17.5% revenue increase. The decline is attributed to exceptional expenses. The hospital business continues to grow, with strong performance in key specialties.

Fortis Healthcare Reports Q3 Results with Profit Decline - 13 Feb, 2026

Fortis Healthcare has experienced a range breakout with bullish divergence, indicating renewed buying interest. The stock is recommended for purchase between ₹895 and ₹880, with a target of ₹970 and a stop loss at ₹840.

Fortis Healthcare Shows Bullish Momentum - 11 Feb, 2026

IHH Healthcare and its subsidiary Fortis Healthcare have launched IHH Catalyst, a national platform aimed at enhancing patient-centric, technology-enabled solutions in India's healthcare system.

Fortis Healthcare Launches National Innovation Platform - 10 Feb, 2026

Fortis Healthcare Limited has announced a board meeting on February 13, 2026, to approve the unaudited financial results for Q3 ending December 31, 2025.

Fortis Healthcare Schedules Q3 Results Board Meeting - 06 Feb, 2026

The Union Budget 2026 highlights healthcare's importance, introducing the Biopharma Shakti initiative and proposing regional medical hubs to enhance medical tourism and attract international patients.

Union Budget Boosts Healthcare Sector Initiatives - 02 Feb, 2026

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

In the last 1 year, FORTIS has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services

This section gives you an insight into why this company has been the best in its industry for the last 1 year.

Best in 1 Year

In the last 3 years, FORTIS has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services

This section gives you an insight into why this company has been the best in its industry for the last 3 years.

Best in 3 Years

Promoters holdings remained unchanged at 31.17% of holdings in Dec 2025 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Unchanged

Retail Investor have decreased holdings from 11.79% to 11.67% in Dec 2025 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Down

Netprofit is down for the last 2 quarters, 321.92 Cr → 193.73 Cr (in ₹), with an average decrease of 39.8% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Down

Revenue is down for the last 2 quarters, 2.38K Cr → 2.27K Cr (in ₹), with an average decrease of 4.4% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Fall

Mutual Funds have decreased holdings from 24.92% to 24.22% in Dec 2025 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Down

In the last 7 days, FORTIS stock has moved down by -4.3%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Dip

Foreign Institutions have decreased holdings from 27.90% to 27.84% in Dec 2025 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

BSE Healthcare

Nifty 200

Nifty MidSmallcap 400

BSE 200

Nifty Healthcare

Nifty Midcap 150

Nifty LargeMidcap 250

Nifty Midcap 100

S&P BSE MidCap Select

Nifty Alpha 50

Nifty 500

S&P BSE Momentum

S&P BSE 250 LargeMidCap

Nifty Midcap 50

S&P BSE 150 MidCap

S&P BSE 400 MidSmallCap

BSE 500

HDFC Mid Cap Fund -Direct Plan - Growth Option

Kotak Midcap Fund Direct Growth

Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap

Axis Midcap Fund Direct Plan Growth

HDFC Small Cap Fund-Direct Growth Option

Fortis Healthcare Ltd’s net profit fell -21.85% since last year same period to ₹193.73Cr in the Q3 2025-2026. On a quarterly growth basis, Fortis Healthcare Ltd has generated -39.82% fall in its net profits since last 3-months.

Fortis Healthcare Ltd Earnings Results

In the quarter ending March 2025, Fortis Healthcare Ltd has declared dividend of ₹1.00 per share on 20 May 2025 - translating a dividend yield of 0.22%.

Name	Value	Action
MACD level (12,26)	-0.28	Bullish
CCI (20)	559.21	Bearish
RSI (14)	50.59	Neutral
Momentum (10)	0.95	Bullish
ADI (14)	32.57	Bullish
Ultimate Oscillator (7,14,28)	15.43	Bearish

Name	Value	Action
SMA (20)	892.33	Bullish
EMA (20)	892.75	Bullish
VWMA (20)	892.63	Bullish
SMA (50)	894.02	Bearish
EMA (50)	894.27	Bearish
SMA (200)	900.34	Bearish
EMA (200)	900.27	Bearish
KAMA (200)	893.38	Bearish
DEMA (200)	894.31	Bearish

Fortis Healthcare Ltd (FORTIS)

Summary

Overall

Oscillators

Moving Averages